Antimicrobial Resistance in India: Bridging the Gap Between Policy and Practice Through a One Health Approach

Authors

  • Dr Ashwini Katole Assistant Professor, Dept. of Community and Family Medicine (CFM), All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, India
  • Dr Purushottam Giri Professor & Head, Dept. of Community Medicine, Indian Institute of Medical Science & Research (IIMSR) Medical College, Badnapur Dist. Jalna, Maharashtra, India
  • Dr Anupriya Jha Assistant Professor, Dept. of Community Medicine, Shri Balaji Institute of Medical Science (SBIMS), Raipur, Chhattisgarh, India https://orcid.org/0000-0001-5332-8307

Keywords:

Antimicrobial resistance, One Health, National Action Plan, Antimicrobial Stewardship

Abstract

A big and growing concern for public health around the world is antimicrobial resistance (AMR). India is a low- and middle-income country with a lot of infectious diseases and AMR makes it harder to stop and cure infectious disease making it a major concern again. India is facing more problems than other countries because of widespread misuse of antimicrobials, inconsistent enforcement of rules, and problems with the health system. India has come up with a detailed policy approach to this problem called the National Action Plan on Antimicrobial Resistance (NAP-AMR). The latest version of the World Health Organisation's Global Action Plan NAP-AMR 2.0 (2025–2029) contains the One Health strategy. But even all of these couldn't regulate it very well, which shows the contrast between what the policy says and what it does. This review not only compiles existing knowledge regarding the prevalence and dissemination of antimicrobial resistance (AMR) in India but also enumerates the primary factors contributing to resistance in humans, animals, and the environment. This review tries to evaluate the progress, milestones, and shortcomings of national AMR strategies. The study demonstrates the significance of an integrated national action plan by coordinating epidemiological data with policy responses, clarifying the importance of implementation and the challenges that remain. The summary highlights the most crucial gaps and steps that need to be taken to make sure that policy pledges really help public health. To bridge the gap between policy and practice in India, we need long-term political commitment, cooperation across sectors, greater leadership, and systems of accountability.

Downloads

Download data is not yet available.

References

World Health Organisation. Antimicrobial resistance. WHO fact sheet. Geneva: WHO; 2024. Availablefrom:https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.

Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-55. doi:10.1016/S0140-6736(21)02724-0

Kotwani A, Joshi J, Lamkang AS. Over-the-counter sale of antibiotics in India: a qualitative study of providers' perspectives across two states. Antibiotics. 2021;10(9):1123. doi:10.3390/antibiotics10091123.

Chalotra R, Khajuria N, Zaffer I, et al. Pattern in the Antibiotic Prescribing Practices at Primary Health Settings in India: A Systematic Review and Meta-Analysis. Cureus 17(10): e93812. DOI 10.7759/cureus.93812

Government of India. National Action Plan on Antimicrobial Resistance (NAP-AMR) 2025–2029. New Delhi: Ministry of Health and Family Welfare, 2025.

O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. London: Review on Antimicrobial Resistance; 2016.

Indian Council of Medical Research. Antimicrobial Resistance Surveillance Network Annual Report. New Delhi: ICMR; 2023.

National Centre for Disease Control. National antimicrobial resistance surveillance report. New Delhi: NCDC; 2023.

Gandra S, Tseng KK, Arora A, et al. The mortality burden of multidrug-resistant pathogens in India. Clin Infect Dis. 2019;69(4):563–570.

National Centre for Disease Control. First multicentric point prevalence survey of antibiotic use in India. New Delhi: NCDC; 2022.

Drug-resistant infections: a threat to our economic future. Washington (DC): World Bank Group; 2017.

Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903–3910.

Food and Agriculture Organisation of the United Nations2024. Surveillance data of the Indian Network for Fishery and Animal Antimicrobial Resistance (INFAAR) – An analytical report 2019–2022. New Delhi. https://doi.org/10.4060/cc9303en

Ranjalkar J, Chandy SJ. India's National Action Plan for antimicrobial resistance – An overview of the context, status, and way ahead. J Family Med Prim Care 2019;8:182834.

Mathew P, Thomas SA, Chandy SJ. The role of schedule H1 and red line campaign in improving antibiotic use in India.J Family Med Prim Care 2022;11:2656-61.

Farooqui HH, Selvaraj S, Mehta A, Mathur MR. The impact of stringent prescription-only antimicrobial sale regulation (Schedule H1) in India: an interrupted time series analysis, 2008–18. J Antimicrob Chemother. 2020;75(10):2910-2918

Kuttikkunnummal A, Sivan S P, Divakaran D, et al. Awareness of Antibiotic Resistance Among Medical Professionals in Kerala,India: A Cross-Sectional Study. Cureus 17(10): e95204. DOI 10.7759/cureus.95204

Veerabhadra Swamy GS, Neelambike Sumana M, Eshwarappa CS, Srinivas SC, et al. Innovative approaches to AMR education: evaluating the impact of gamification on empowering ASHA workers' knowledge and engagement in Mysuru, India. BMC Med Educ. 2025;25:1542. doi:10.1186/s12909-025-08092-9.

Published

2026-03-20

How to Cite

1.
Katole DA, Giri DP, Jha A. Antimicrobial Resistance in India: Bridging the Gap Between Policy and Practice Through a One Health Approach. Indian Journal of Community Health [Internet]. 2026 Mar. 20 [cited 2026 Mar. 29];38(1). Available from: https://www.iapsmupuk.org/journal/index.php/IJCH/article/view/3496

Issue

Section

Review Article

Dimensions Badge